Latest content

  • Quickly screen for optimal expression levels and thermal stability for your toughest membrane proteins

    Quickly screen for optimal expression levels and thermal stability for your toughest membrane proteins

    Read

  • Working in targeted protein degradation?

    Learn a new approach to discover and characterize E3 ligase ligands.

    Register for event
  • Fast expression screening that reveals expression levels of properly folded recombinant proteins

    Fast expression screening that reveals expression levels of properly folded recombinant proteins

    Read
  • Maximize stability & function of SARS-CoV-spike protein and ACE2 receptor using Monolith & Prometheus33:11

    Maximize stability & function of SARS-CoV-spike protein and ACE2 receptor using Monolith & Prometheus

    Dr. Leah Pandiscia and Dr. Daniel Turman review how to integrate the Prometheus Panta and Monolith instruments in a characterization workflow demonstration, showing how to maximize stability and funct

    Watch
  • Mechanisms for protein aggregation and stabilization in solution, during freezing and drying, and at interfaces29:22

    Mechanisms for protein aggregation and stabilization in solution, during freezing and drying, and at interfaces

    Learn about the causes of protein aggregation and how to implement the best solutions to enhance protein stability with Dr. John Carpenter from the University of Colorado. He presented as one of three

    Watch
  • Molecular interactions - a simple framework: Energy, energy, energy27:20

    Molecular interactions - a simple framework: Energy, energy, energy

    Explore the complexities and drivers of molecular interactions with Dr. Tom Laue from the University of New Hampshire. He presented as a keynote speaker in the Protein Stability & Function: Can't have

    Watch

  • Have a question?

    Contact Specialist
  • Confirmation of the "Conformation" is key for drug discovery and development22:36

    Confirmation of the "Conformation" is key for drug discovery and development

    Hear how Dr. Sathya Venkataramani from Janssen Biotherapeutics maximized protein stability using the Prometheus in a real life case study about the design and characterization of antibody-based drugs.

    Watch
  • ×

    Sign up to receive
    the latest NanoTemper news, product updates, event announcements and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • 5 experiments in biologics that can be improved with dynamic light scattering

    5 experiments in biologics that can be improved with dynamic light scattering

    Biologics, which are drugs and treatments derived from natural products, undergo a long development process before they reach the clinic. When you invest a lot of time and money in the process to...

    Read
  • NanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe

    NanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe

    NanoTemper Technologies and SIRION Biotech, two of Munich’s rapidly growing biotech companies, are lending their support to Adrian Bleninger, a 30-year-old Bavarian sailor, in his bid to qualify...

    Read
  • Targeted protein degradation promises to lead the way to effective drugs for challenging targets

    Targeted protein degradation promises to lead the way to effective drugs for challenging targets

    Read
  • NanoTemper named one of Germany’s most innovative companies in 2021 by Capital

    NanoTemper named one of Germany’s most innovative companies in 2021 by Capital

    For the second year in a row, NanoTemper was named one of the most innovative companies in Germany by Capital magazine. A five out of five star distinction placed NanoTemper in the ranking’s top...

    Read
  • Protein degraders show promising results in drug development pipelines. See what progress candidates have made.

    Protein degraders show promising results in drug development pipelines. See what progress candidates have made.

    There has been considerable and promising development in the field of targeted protein degradation (TPD) since the seminal discovery of PROTACs in 2001.1 The appeal of degraders like PROTACs lies...

    Read
  • Let's catalyze - biophysical insights into enzymes1:32:25

    Let's catalyze - biophysical insights into enzymes

    Enzymes are nature's engine for many processes. Diving into the stability and function of enzymes will give us a better understanding of these processes. In this webinar, you will learn: -what biophy

    Watch
  • NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021

    NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021

    NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development....

    Read
  • Is your screening campaign stuck? 3 signs that it’s time to look for an alternative biophysical technology

    Is your screening campaign stuck? 3 signs that it’s time to look for an alternative biophysical technology

    Most labs dedicated to drug discovery — in big pharma, biopharma, or CROs — make it a priority to have an adequate lineup of instruments for their screening campaigns. They decide on what...

    Read
  • Are you building an effective protein degrader?

    Are you building an effective protein degrader?

    Read
  • Tour Prometheus Panta: How to make your formulation workflow more efficient with multi-parameter stability characterization42:46

    Tour Prometheus Panta: How to make your formulation workflow more efficient with multi-parameter stability characterization

    Join this case study and walk through of Prometheus Panta. Make your formulation workflow more efficient and effective with simultaneous, multi-parameter stability characterization. What you’ll lear

    Watch
  • Are you building an effective protein degrader? 4 questions to ask yourself to find out

    Are you building an effective protein degrader? 4 questions to ask yourself to find out

    Protein degraders are getting a lot of attention for being a new and promising modality to treat diseases such as cancer or Alzheimer’s disease. Rather than inhibiting the function of a protein,...

    Read
  • NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

    NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

    NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets. PRESS RELEASE MUNICH, Germany, 24 March...

    Read
  • Prometheus Panta: The next frontier in protein stability characterization1:06:54

    Prometheus Panta: The next frontier in protein stability characterization

    Join this e-demo on the Prometheus Panta. Learn how to collect thermal unfolding, particle sizing, and aggregation data on a single platform using the NIST mAb. The growing complexity of therapeutic

    Watch
  • Follow these 7 tips when pipetting small volumes to get consistent assay results

    Follow these 7 tips when pipetting small volumes to get consistent assay results

    If you’ve ever had to pipette really small volumes, such as what is required in 384-well plates, you’re definitely familiar with the frustrations that come along with it. The concentration alone...

    Read

  • Have a question?

    Contact Specialist
  • loading
    Loading more...
See more